Combined Treatment with Oral metronidazole and N-acetylcysteine is Effective in Ethylmalonic Encephalopathy
Publication Type
Original research
Authors
  • Carlo Viscomi
  • Alberto B Burlina
  • Imad Dweikat
  • Mario Savoiardo
  • Costanza Lamperti
  • Tatjana Hildebrandt
  • Valeria Tiranti
  • Massimo Zeviani
Fulltext
Download

Ethylmalonic encephalopathy is caused by mutations in ETHE1, a mitochondrial matrix sulfur dioxygenase, leading to failure to detoxify sulfide, a product of intestinal anaerobes and, in trace amounts, tissues. Metronidazole, a bactericide, or N-acetylcysteine, a precursor of sulfide-buffering glutathione, substantially prolonged the lifespan of Ethe1-deficient mice, with the combined treatment being additive. The same dual treatment caused marked clinical improvement in five affected children, with hardly any adverse or side effects.

Journal
Title
Nature Medicine 16, 869–871, (2010), doi:10.1038/nm.2188
Publisher
--
Publisher Country
Palestine
Publication Type
Both (Printed and Online)
Volume
--
Year
2010
Pages
--